Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
Sun Yat-sen University · Sun Yat-sen University Cancer Center · +21 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
49
total citations
- FWCI
- 33.57
- Percentile
- 100%
- References
- 34
Citations per year
Authors
22- DRDan-Yun RuanCorresponding
Sun Yat-sen University, Sun Yat-sen University Cancer Center
- FLFurong Liu
Sun Yat-sen University, First Hospital of China Medical University, Sun Yat-sen University Cancer Center, China Medical University
- XWXiao-Li Wei
Sun Yat-sen University, Sun Yat-sen University Cancer Center
- SLSu-Xia Luo
Zhengzhou University, Henan Cancer Hospital
- ZZZhixiang Zhuang
Soochow University, Second Affiliated Hospital of Soochow University
Topics & keywords
Topics
Keywords
- Medicine
- Adverse effect
- Internal medicine
- Regimen
- Cancer
- Gastroenterology
- Response Evaluation Criteria in Solid Tumors
- Phases of clinical research
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.